TENAX THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Tenax Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q4 2023.
  • Tenax Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $38.7M, a 3.08% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $38.7M +$1.16M +3.08% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $37.5M +$1.91M +5.37% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $35.6M -$486K -1.35% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $36.1M +$657K +1.85% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $35.4M +$1.64M +4.86% Dec 31, 2019 10-K/A 2021-04-16
Q4 2018 $33.8M +$1.01M +3.09% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $32.8M -$14.3M -30.4% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $47.1M +$7.22M +18.1% Dec 31, 2016 10-K 2018-04-02
Q4 2015 $39.9M Dec 31, 2015 10-K 2017-03-16
Q1 2015 $36M +$5.05M +16.3% Apr 30, 2015 10-KT 2016-03-14
Q1 2014 $30.9M +$58.7M Apr 30, 2014 10-KT 2016-03-14
Q1 2013 -$27.8M -$1.9M -7.35% Apr 30, 2013 10-K 2014-07-29
Q1 2012 -$25.9M Apr 30, 2012 10-K 2013-06-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.